| Stage | JNJ | % of rev | ABBV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $25.4B | 100.00% | $17.0B | 100.00% | JNJ ×1.49 |
| Gross profit | $17.3B | 68.12% | $12.4B | 73.03% | ABBV +4.9pp |
| Operating income | $5.8B | 23.01% | $6.4B | 37.86% | ABBV +14.8pp |
| Pre-tax income | $34M | 0.13% | $4.3B | 25.18% | ABBV +25.0pp |
| Net income | $210M | 0.83% | $3.6B | 21.28% | ABBV +20.5pp |
| Stage | JNJ | ABBV | Gap · A − B |
|---|---|---|---|
| Revenue | $25.4B100.00% | $17.0B100.00% | JNJ ×1.49 |
| Gross profit | 68.12%$17.3B | 73.03%$12.4B | ABBV +4.9pp |
| Operating income | 23.01%$5.8B | 37.86%$6.4B | ABBV +14.8pp |
| Pre-tax income | 0.13%$34M | 25.18%$4.3B | ABBV +25.0pp |
| Net income |
| 0.83%$210M |
| 21.28%$3.6B |
| ABBV +20.5pp |
No shared counterparties.